This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Islam et al.1 describe an unusually high frequency of the axonal variants of Guillain-Barré syndrome (GBS) with Campylobacter jejuni infection, severe residual disability, and high mortality.
Previous reports have also shown a high proportion of axonal variants of GBS in Asia.2 However, we have several concerns about the interpretation of the outcome analysis. We are concerned about a potential selection bias in this study. Due to the relatively high mortality (14%) and severe residual disability, we suspect the results were confounded by a selection bias. The 3 hospitals involved in this study are the largest hospitals in Bangladesh, which may admit more severely ill patients than smaller facilities.
In addition, many patients …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Alert Me
Recommended articles
Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh
Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies
Antecedent infections in Fisher syndrome
Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Campylobacter jejuni Infection